Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism

European Journal of Pharmacology

Volumn 363, Issue 2-3, 1998, Pages 107-112

  Makisumi, Toshirou ^a   Yoshida, Ken ichi ^a   Watanabe, Tatsuo ^a   Tan, Nobusuke ^a   Murakami, Naotoshi ^a   Morimoto, Akio ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenal gland; Glucocorticoid; Hyperthermia; Methamphetamine; Sympathetic nerve system

Indexed keywords

AMPHETAMINE; DANTROLENE; DEXAMETHASONE; METHAMPHETAMINE; OXIDOPAMINE;

ADRENALECTOMY; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; HYPERTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORADRENALIN RELEASE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SUBCUTANEOUS DRUG ADMINISTRATION; TELEMETRY; THERMOGENESIS;

ADRENAL GLANDS; ADRENALECTOMY; ANIMALS; BODY TEMPERATURE; FEVER; MALE; METHAMPHETAMINE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 0032545462     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00758-4     Document Type: Article

References (39)

1. Antelman S.M., Eichler A.J., Black C.A., Kocan D. Interchangeability of stress and amphetamine in sensitization. Science. 207:1980;329-331.
2. Askew B.M. Hyperpyrexia as a contributing factor in the toxicity of amphetamine in aggregated mice. Br. J. Pharmacol. 19:1962;245-257.
3. Astrup A., Bulow J., Madsen J., Christensen J. Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. Am. J. Physiol. 248:1985;E507-E515.
4. Badiani A., Morano M.I., Aki H., Robinson T.E. Circulating adrenal hormones are not necessary for the development of sensitization to the psychomotor activating effects of amphetamine. Brain Res. 673:1995;13-24.
5. Blaak E.E., Van Baak M.A., Kempen K.P.G., Saris W.H.M. Role of α and β adrenoceptors in sympathetically mediated thermogenesis. Am. J. Physiol. 264:1993;E11-E17.
6. Borbely A.A., Baumann I.R., Waser P.G. Amphetamine and thermoregulation: studies in the unrestrained and curarized rat. Arch. Pharmacol. 281:1974;327-340.
7. Britt B.A. Dantrolene - review article. Can. Anaesth. Soc. J. 31:1984;61-75.
8. Bukowiecki L., Jahjah L., Follea N. Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta adrenoceptors. Int. J. Obes. 6:1982;343-350.
9. Cador M., Dulluc J., Mormede P. Modulation of the locomotor response to amphetamine by corticosterone. Neuroscience. 56:1993;981-988.
10. Callaway C.W., Clark R.F. Hyperthermia in psychostimulant overdose. Ann. Emerg. Med. 24:1994;68-76.
11. Clark C.W., Blackman H.J., Preston J.E. Certain factors in aggregated mice D-amphetamine toxicity. Arch. Int. Pharmacodyn. 170:1967;350-363.
12. Cox B., Ennis C., Lee T.F. The function of dopamine receptors in the central thermoregulatory pathways of the rat. Psychopharmacology. 20:1981;1047-1051.
13. De Luca B., Monda M., Amaro S., Pellicano M.P., Cioffi L.A. Thermogenic changes following frontal neocortex stimulation. Brain Res. Bull. 22:1989;1003-1007.
14. Deroche V., Piazza P.V., Maccari S., Lemoal M., Simon H. Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Res. 584:1992;309-313.
15. Faunt J.E., Crocker A.D. Adrenocortical hormone status affects responses to dopamine receptor agonists. Eur. J. Pharmacol. 152:1988;255-261.
16. Foster D.O. Quantitative contribution of brown adipose tissue to overall metabolism. Can. J. Biochem. Cell Biol. 62:1984;618-622.
17. Frey H.H. Hyperthermia induced by amphetamine, p-chloroamphetamine and fenfluramine in rat. Pharmacology. 13:1975;163-176.
18. Ganong, F.W., 1991. Review of Medical Physiology, 15th edn. Appleton & Lange, East Norwalk, CT.
19. Gordon C.J., Watkinson W.P., O'Callaghan J.P., Miller D.B. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of rat. Pharmacol. Biochem. Behav. 38:1991;339-344.
20. Haggendal J., Johnson L., Johnson G., Bjurstorm S., Carlsten J. Disordered catecholamine release in pigs susceptible to malignant hyperthermia. Pharmacol. Toxicol. 63:1988;257-261.
21. Himmis-Hagen J. Non-shivering thermogenesis. Brain Res. Bull. 12:1984;151-160.
22. Johnson D.H., Svensson A.I., Engel J.A., Soderpalm B. Induction but not expression of behavioral sensitization to nicotine in the rat is dependent on glucocorticoids. Eur. J. Pharmacol. 276:1995;155-164.
23. Knych E.T., Eisenberg R.M. Effect of amphetamine on plasma corticosterone in the conscious rat. Neuroendocrinology. 29:1979;110-118.
24. Kopin, J.I., 1987. Psychopharmacology, The Third Generation of Progress, 1st edn. Raven Press, New York.
25. Lange J., Brockway B., Azan S. Telemetric monitoring of laboratory animals: an advanced technique that has come of age. Lab. Anim. 20:1991;28-34.
26. Lin M.T. Effects of dopaminergic antagonist and agonist on thermoregulation in rabbits. J. Physiol. 293:1979;217-228.
27. Lin M.T., Chandra A., Chern Y.F., Tsay B. Effects of intracerebroventricular injection of D-amphetamine on metabolic, respiratory, and vasomotor activities and body temperatures in the rats. Can. J. Physiol. Pharmacol. 58:1980;903-908.
28. Maccari S., Lemoal M., Abgelucci L., Mormede P. Influence of 6-OHDA lesion of central noradrenergic systems on corticosteroid receptors and neuroendocrine responses to stress. Brain Res. 533:1990;60-65.
29. Makisumi T., Yoshida K., Nakamori T., Morimoto A. Cardiovascular response to methamphetamine is mediated by corticotropin-releasing factor (CRF) and enhanced by stress. Biogenic Amines. 11:1995;247-253.
30. Matsumoto C., Griffin W. Antagonism of (+)-amphetamine-induced hyperthermia in rats by pimozide. J. Pharm. Pharmacol. 23:1971;710.
31. Ohta T., Endo M. Inhibition of calcium-induced calcium release by dantrolene at mammalian body temperature. Proc. Japan Acad. 62:1986;329-332.
32. Pauly J.R., Robinson S.F., Collins A.C. Chronic corticosterone administration enhances behavioral sensitization to amphetamine in mice. Brain Res. 620:1993;195-202.
33. Rivet J.M., Stinus L., LeMoal M., Mormede P. Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res. 498:1989;149-153.
34. Singarajah C., Lavies G.N. An overdose of ecstasy, a role for dantrolene. Anaesthesia. 47:1992;686-687.
35. Vogel W.H., Miller J., DeTurck K.H., Routzahn B.K. Jr. Effects of psychoactive drugs on plasma catecholamines during stress in rats. Neuropharmacology. 23:1984;1105-1108.
36. Ward A., Chaffman M., Sorkin E. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs. 32:1986;130-168.
37. Yamawaki S., Lai H., Horita A. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine. J. Pharmacol. Exp. Ther. 227:1983;383-388.
38. Yoshida K., Morimoto A., Makisumi T., Murakami N. Cardiovascular, thermal and behavioral sensitization to methamphetamine in freely moving rats. J. Pharmacol. Exp. Ther. 267:1993;1538-1543.
39. Zalis E.G., Lundberg G.D., Knutson R.A. The pathophysiology of acute amphetamine poisoning. J. Pharmacol. Exp. Ther. 158:1967;115-127.